Skip to main content

Table 1 Demographical and clinical data for the study population a

From: Anti-Saccharomyces cerevisiae antibodies (ASCA) are associated with body fat mass and systemic inflammation, but not with dietary yeast consumption: a cross-sectional study

 

All patients, n = 140 b

Age, years

43.1 (8.7)

Gender (male/female)

31 (22%)/109 (78%)

Ethnic Nordic background

138 (99%)

Height, cm

169 (149–197)

Weight, kg

120 (90–192)

BMI, kg/m2

41.6 (35–55)

Body fat, percentage of body weight

46.8 (31–51)

Body fat mass, kg

54.1 (39–81)

Smoking (never/former/current)

55 (39%)/60 (43%)/25 (18%)

Previous or present co-morbidity

 Diabetes mellitus

26 (19%)

 Polycystic ovary syndrome

7 (6.4%)

 Hypertension

46 (33%)

 Angina pectoris

1 (0.7%)

 Myocardial infarction

2 (1.4%)

 Stroke

3 (2.1%)

 Fibromyalgia

25 (18%)

 Hypothyroidism

18 (13%)

 Hyperthyroidism

1 (0.7%)

 Gallstones

21 (15%)

 Irritable bowel syndrome (Rome III)

35 (26%)

 Chronic obstructive pulmonary disease

3 (2.1%)

 Asthma

34 (24%)

 Hay fever

19 (14%)

 Osteoporosis

0 (0%)

 Asked for help for psychological problems

28 (20%)

 Mental distress (HSCL-10 score > 1.85)

34 (24%)

  1. aData are expressed as mean (SD), median (min-max) and n (%)
  2. bAll data are based on n = 140 with the following exceptions: 1) Irritable bowel syndrome: n = 135. 2) Polycystic ovary syndrome; n = 109 (females only)